Beckley Psytech Begins Phase IIa Study of 5-MeO-DMT to Treat Alcohol Use Disorder
A Phase IIa clinical trial of 5-MeO-DMT for the treatment of alcohol use disorder (AUD) has begun this month.
A Phase IIa clinical trial of 5-MeO-DMT for the treatment of alcohol use disorder (AUD) has begun this month.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.